» Articles » PMID: 38831162

A Guide to Adaptive Immune Memory

Overview
Journal Nat Rev Immunol
Date 2024 Jun 3
PMID 38831162
Authors
Affiliations
Soon will be listed here.
Abstract

Immune memory - comprising T cells, B cells and plasma cells and their secreted antibodies - is crucial for human survival. It enables the rapid and effective clearance of a pathogen after re-exposure, to minimize damage to the host. When antigen-experienced, memory T cells become activated, they proliferate and produce effector molecules at faster rates and in greater magnitudes than antigen-inexperienced, naive cells. Similarly, memory B cells become activated and differentiate into antibody-secreting cells more rapidly than naive B cells, and they undergo processes that increase their affinity for antigen. The ability of T cells and B cells to form memory cells after antigen exposure is the rationale behind vaccination. Understanding immune memory not only is crucial for the design of more-efficacious vaccines but also has important implications for immunotherapies in infectious disease and cancer. This 'guide to' article provides an overview of the current understanding of the phenotype, function, location, and pathways for the generation, maintenance and protective capacity of memory T cells and memory B cells.

Citing Articles

A variational deep-learning approach to modeling memory T cell dynamics.

van Dorp C, Gray J, Paik D, Farber D, Yates A bioRxiv. 2025; .

PMID: 40060443 PMC: 11888226. DOI: 10.1101/2024.07.08.602409.


Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing.

Xu Y, Bai X, Lin J, Lu K, Weng S, Wu Y Mol Ther Methods Clin Dev. 2025; 33(1):101420.

PMID: 40034424 PMC: 11874542. DOI: 10.1016/j.omtm.2025.101420.


Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort.

Wullimann D, Sandberg J, Akber M, Lofling M, Gredmark-Russ S, Michaelsson J PLoS Negl Trop Dis. 2025; 19(2):e0012693.

PMID: 40019865 PMC: 11893121. DOI: 10.1371/journal.pntd.0012693.


Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell.

Olsthoorn S, van Krimpen A, Hendriks R, Stadhouders R Immunol Rev. 2025; 330(1):e70010.

PMID: 40016948 PMC: 11868696. DOI: 10.1111/imr.70010.


The Interplay of Nutrition, the Gut Microbiota and Immunity and Its Contribution to Human Disease.

Dawson S, Todd E, Ward A Biomedicines. 2025; 13(2).

PMID: 40002741 PMC: 11853302. DOI: 10.3390/biomedicines13020329.


References
1.
Bekkering S, Dominguez-Andres J, Joosten L, Riksen N, Netea M . Trained Immunity: Reprogramming Innate Immunity in Health and Disease. Annu Rev Immunol. 2021; 39:667-693. DOI: 10.1146/annurev-immunol-102119-073855. View

2.
Fuentes S, Coyle E, Beeler J, Golding H, Khurana S . Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins. PLoS Pathog. 2016; 12(4):e1005554. PMC: 4839671. DOI: 10.1371/journal.ppat.1005554. View

3.
Gouma S, Kim K, Weirick M, Gumina M, Branche A, Topham D . Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility. Nat Commun. 2020; 11(1):4566. PMC: 7486384. DOI: 10.1038/s41467-020-18465-x. View

4.
Zheng Z, Warren J, Shapiro E, Pitzer V, Weinberger D . Estimated incidence of respiratory hospitalizations attributable to RSV infections across age and socioeconomic groups. Pneumonia (Nathan). 2022; 14(1):6. PMC: 9592130. DOI: 10.1186/s41479-022-00098-x. View

5.
ODriscoll M, Ribeiro Dos Santos G, Wang L, Cummings D, Azman A, Paireau J . Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2020; 590(7844):140-145. DOI: 10.1038/s41586-020-2918-0. View